Valued Wealth Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5K Buy
313
+122
+64% +$9.84K 0.01% 163
2026
Q1
$13.5K Sell
191
-42
-18% -$3.14K 0.01% 240
2025
Q4
$18.4K Buy
233
+33
+17% +$2.61K 0.01% 167
2025
Q3
$16.5K Buy
200
+10
+5% +$787 0.01% 175
2025
Q2
$15.3K Buy
190
+53
+39% +$4.09K 0.01% 172
2025
Q1
$11K Buy
137
+15
+12% +$1.25K 0.01% 212
2024
Q4
$10K Buy
122
+43
+54% +$3.58K 0.01% 228
2024
Q3
$6.52K Sell
79
-14
-15% -$1.05K ﹤0.01% 258
2024
Q2
$6.53K Buy
93
+34
+58% +$2.43K ﹤0.01% 247
2024
Q1
$4.38K Buy
59
+33
+127% +$2.3K ﹤0.01% 262
2023
Q4
$1.64K Buy
+26
New +$1.63K ﹤0.01% 326

Other funds holding MET

Valued Wealth Advisors's MET Position: Q2 2026 in Review

Valued Wealth Advisors increased its MetLife (MET) stake by 64% in Q2 2026, buying an estimated $9.84K and bringing the position to 313 shares worth $26.5K. The position accounts for 0.01% of the portfolio, ranked #163.

Valued Wealth Advisors first reported a position in MET in Q4 2023 and has held it in 11 quarters since. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Valued Wealth Advisors held 313 shares of MetLife worth $26.5K as of Q2 2026.
  • Valued Wealth Advisors bought 122 MetLife shares in Q2 2026, an estimated $9.84K.
  • MetLife made up 0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #163 holding.
  • Valued Wealth Advisors first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.